TORONTO, ONTARIO -- (MARKET WIRE) -- November 10, 2006 -- Covalon Technologies Ltd. (the “Corporation” or “Covalon”) (TSX VENTURE: COV) announced that it has received important US Medicare HCPCS reimbursement codes for its ColActive and ColActiveAg wound dressings. The Centers for Medicare & Medicaid Services of the United States have approved Covalon’s dressings for reimbursement as collagen dressings. The Statistical Durable Medical Equipment Regional Carrier has determined that the Medicare GCPCS code to bill the four Durable Medical Equipment Regional Carriers (DMERCs) is A6021 Collagen dressing, pad size of 16 square inches or less, each.
